GlassScriptPhysician profile
James H Stanley
NPI 1861476681
$7,540.69
in general payments reported to CMS, 2019-2025
21 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $240 · 2021: $789 · 2022: $2,505 · 2023: $2,057 · 2024: $426 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614 · Travel and Lodging: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.93 |
| Travel and Lodging | $1,350.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,486.76 | 2022-2025 | Eterna |
| Si-Bone, INC. | $1,388.26 | 2019-2021 | |
| Vilex LLC | $984.30 | 2023 | |
| Relievant Medsystems, INC. | $891.98 | 2023 | Intracept |
| Providence Medical Technology, INC. | $353.30 | 2021-2024 | |
| Vgi Medical, LLC | $238.50 | 2021 | |
| Medtronic USA, INC. | $185.37 | 2019-2020 | |
| Curonix LLC | $179.15 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $170.61 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Cerapedics INC. | $167.04 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Xtant Medical INC | $153.52 | 2025 | |
| Boston Scientific Corporation | $78.28 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $46.53 | 2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $39.06 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Pylant Medical | $36.31 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $36.17 | 2021 | |
| Arteriocyte Medical Systems, INC. | $31.26 | 2022-2024 | Magellan |
| Innovation Technologies INC | $24.79 | 2023 | Irrisept |
| Cpm Medical Consultants, LLC | $20.10 | 2023 | |
| Polynovo North America LLC | $17.10 | 2024 | Novosorb Btm |
| Cumberland Pharmaceuticals, INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.